Thymopoietin Antikörper (N-Term)
Kurzübersicht für Thymopoietin Antikörper (N-Term) (ABIN1450080)
Target
Alle Thymopoietin (TMPO) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- N-Term
-
Kreuzreaktivität (Details)
- Species reactivity (tested):Human, Mouse.
-
Aufreinigung
- Affinity chromatography purified via peptide column
-
Immunogen
- 19 amino acid synthetic peptide near the amino terminus of Human Thymopoietin
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Konzentration
- 1.0 mg/mL
-
Buffer
- PBS containing 0.02 % Sodium Azide as preservative
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Avoid repeated freezing and thawing.
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
-
-
- Thymopoietin (TMPO)
-
Hintergrund
- Thymopoietin (TMPO), also known as LAP2, is a widely expressed lem-domain-containing nuclear protein that is thought to play an important role in the regulation of nuclear architecture by binding lamin B1 and chromosomes in a manner regulated by phosphorylation during mitosis. Thymopoietin associates with nucleoplasmic lamins A/C, which are encoded by the dilated cardiomyopathy (DCM) gene LMNA, mutations in Thymopoietin disrupt this binding, suggesting that Thymopoietin may be a candidate disease gene for DCM.Synonyms: Lamina-associated polypeptide 2 isoform alpha, Thymopoietin isoform alpha, Thymopoietin-related peptide isoform alpha
-
Gen-ID
- 7112
-
NCBI Accession
- NP_003267
Target
-